Nordic AML Insights – June Update: Research and EHA Congress

This June update offers an overview of recent research on acute myeloid leukemia (AML) from the Nordic countries. It covers a range of topics, including geographic distribution patterns in Denmark, survival trends over the past 50 years, and new clinical trial results exploring treatment options. Additionally, highlights from the EHA 2025 Congress showcase promising advances such as optimized drug regimens and novel immune escape pathways in AML.